Respiratory diseases in pregnancy بتول عبد الواحد هاشم0د Asthma Prevalence in pregnancy 1-4% The effect of pregnancy on asthma: 2/5 will deteriorate, 2/5 will stay the same, and 1/5 will improve, women with severe asthma seem more likely to deteriorate, those showing improvement during pregnancy are more likely to suffer postpartum relapse. Management of asthma in pregnancy: Management of asthma in pregnancy is essentially the same as in non pregnant patients. Prevention is the key, known triggers of exacerbations should be avoided. Pharmacological treatment of asthma: This follows a step by step approach: Step1 occasional relief bronchodilator (short acting inhaled B2ag.) Step2 regular inhaled preventative (short acting inhaled B2ag.+inhaled standard dose CS— corticosteroids) Step3high dose inhaled corticosteroids ( short acting inhaled B2ag + high dose inhaled corticosteroids.) Step4 high dose inhaled corticosteroids+regular bronchodilators. Step5 regular corticosteroids tablets. Short and long acting B2 agonists, inhaled steroids and theophyllin can all be used in pregnancy. Neonatal apnoea and irritability were reported with theophyllin use during pregnancy, but this should not inhibit it's use whenever indicated. Women with more severe asthma who have been stabilized on leukotrienereceptor antagonists may continue them throughout pregnancy. It's less likely that pregnant patient will be using antimuscarinic bronchodilators or sodium cromoglycate, however; no adverse effects have been reported in pregnancy. Prednisolone is the CS used in pregnancy as 88% of it is metabolized by the placenta, limiting fetal exposure, however; there's statistically significant 3folds increase in oral clefting with 1 steroids use in 1st trimesters, neonatal adrenal suppression has proven to be a theoretical risk rather than a real practical concern, anxieties about associations with IUGR, neuronal development, long term hypertension and preterm labour, if real , these complications are likely to occur in the long term users of high doses. CS are usually only prescribed for good medical reasons, and usually outside of the teratogenic period. Managing pregnancy in asthmatic patients: Standard ANC for mild-moderate cases, multidisciplinary team- based ANC for severe cases Base line investigations, such as peak flow measurement should be obtained at booking Medical treatment should be optimized, with repeated reassurance about of these drugs in pregnancy Patient with severe asthma should be observed for signs of preterm labour, follow fetal growth and wellbeing by US Induction of labour and caeserian section reserved for obstetric indications Regional anaesthesia is preferred over general anaesthesia for operative procedures women on prednisolone should be screened for glucose intolerance and measures taken if this was found, those taking prednisolone at the onset of labour should be given supplementary doses of 100mg hydrocortisone6-8hourly until oral intake is resumed ergometrine, prostaglandinsF2α, aspirin, and NSAIDs, should be avoided where possible as they can cause bronchospasm postnatal deterioration should be discussed with the woman breastfeeding is not contraindicated with any of the medications used. Pneumonia Prevalence & outcome : It's no more common in pregnancy than in an age-matched population as a whole, and maternal outcome is no better or worse, fetal outcome; preterm labour is the main risk, however; growth restriction have been reported. Diagnosis of pneumonia in pregnancy:symptoms are same as in non pregnant but may confused with physiological changes common to pregnancy Chest X ray – related fetal exposure with appropriate shielding is minimal and the examination is safe. Sputum should be sent for microbiological exam and culture 2 Blood can be taken for serological testing Treatment of pneumonia in pregnancy: Frequently no infectious agent is found and pneumonia treated impirically Penicillins, macrolides, and cephalosporins are the treatment of choice, non is contraindicated in pregnancy, higher doses of amoxicillin is needed to counteract the increased renal clearance found in pregnancy. Erythromycin and clarithromycin should be added if there is suspicion of atypical pneumonia Cephalosporins is used for penicillin allergic individuals or hospital acquired infections Pneumonia requiring admission usually treated with 3rd generation cephlosporine with erythromycin Amantadine and ribavirin antiviral agent have been used in pregnancy with viral pneumonia with no harmful effect. Tuberculosis: The relationship between pregnancy & TB There is no good evidence to suggest that pregnancy is an independent risk factor for infection with Mycobacterium TB, and it's generally agreed that pregnancy has no impact on the course of TB and that TB if diagnosed and treated properly has no significant impact on the pregnancy. Delayed diagnosis and treatment are both detrimental to both maternal and fetal outcome With increasing risk of preterm labor and IUGR. Presentation and diagnosis are unaffected by pregnancy Vertical transmission is extremely rare and only occur if maternal disease has gone untreated Lateral transmission from mother or other close contact occurring after delivery is more common cause of infant infection Strict criteria exist for diagnosis of congenital TB,one of the following is necessary 1-lesion in the 1st week of life 2- a primary hepatic complex or caseating granuloma 3-histological evidence of placental or endometrial involvement 4-absence of TB in other carer of the c hild 3 Treatment of TB in pregnancy TB is most likely diagnosed by physician and specialist advice of respiratory consultant is essential Isoniazide, rifampicin, and ethambutol are used initially, ethambutol can be stopped when sensitivity to 1st two drugs is adequate, these are then continued for 9 months. Most significant toxic side effect of isoniazide is demylination, this can be prevented by pyredoxin Hepatoxicity may be more common and this followed by monthly liver function test No significant in fetal anomaly rate Liver enzyme induction with theoretical risk of vit. K difficiency should prompt oral vitamin K supplement in 3rd TMS to prevent haemrrhagic disease of newborn Ethambutol is associated with fetal ocular toxicity Pyrizinamide is usually avoided in pregnancy, there are no data to suggest a harmful effect and should be used if needed as a second line agent. Streptomycin has well recognized fetal ototoxicity. All anti TBdrugs mentioned above are compatable with breast feeding Active TBsufferer will become non-infectious within 2 weeks of commencing treatment, the newborn should be immunized with BCGand also given prophylactic antibiotics Placenta should be sent for microbiological exam. Cystic fibrosis: Autosomal recessive condition, the life expectancy of affected women is increasing and many more women are surviving to an age at which pregnancy is possible. It's a multisystemic disorder principally affecting the lung , liver and pancreas, women are typically underweight and many develop diabetes, It's important to check CF carrier status of the husband and the couple should be offered genetic counseling regarding the risks of the fetus having CF or being a carrier. Mothers should be jointly managed by obstetrician and respiratory physician expertise in CF women will have daily physiotherapy regime and will require prolonged antibiotic therapy and hospital admission during exacerbations. If delivery is necessary before 34 week, steroid should be given to improve fetal lung maturation, ideally vaginal delivery should be the aim and epidural analgesia offered, the 2nd stage can be shortened in the event of maternal exhaustion. 4 5